Transcriptional level of inflammation markers associates with short-term brain structural changes in first-episode schizophrenia

[1]  Hui Li,et al.  Characteristics of cognition impairment in patients after stroke based on the Wechsler Adult Intelligence Scale-Revised in China. , 2023, Applied neuropsychology. Adult.

[2]  Long-Biao Cui,et al.  The Xi'an Schizophrenia Imaging Lab (SIL) data and ten years of MRI study on schizophrenia , 2022, Psychoradiology.

[3]  John A. Williams,et al.  Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders , 2022, JAMA psychiatry.

[4]  J. Bishop,et al.  Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies , 2022, Harvard review of psychiatry.

[5]  T. Ge,et al.  Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count , 2021, JAMA psychiatry.

[6]  H. Yin,et al.  rTMS Induces Brain Functional and Structural Alternations in Schizophrenia Patient With Auditory Verbal Hallucination , 2021, Frontiers in Neuroscience.

[7]  Valerie J. Sydnor,et al.  Neurodevelopment of the association cortices: Patterns, mechanisms, and implications for psychopathology , 2021, Neuron.

[8]  S. Lui,et al.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies , 2021, Frontiers in Psychiatry.

[9]  S. Djurovic,et al.  Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness. , 2021, JAMA psychiatry.

[10]  Long-Biao Cui,et al.  Magnetic Resonance Imaging-Guided and Navigated Individualized Repetitive Transcranial Magnetic Stimulation for Cognitive Impairment in Schizophrenia , 2021, Neuroscience Bulletin.

[11]  Dan J Stein,et al.  Brain charts for the human lifespan , 2021, Nature.

[12]  Rajiv P. Sharma,et al.  Monocyte Transcriptional Profiling Highlights a Shift in Immune Signatures Over the Course of Illness in Schizophrenia , 2021, Frontiers in Psychiatry.

[13]  A. Zalesky,et al.  Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder , 2021, Brain, Behavior, and Immunity.

[14]  G. Pearlson,et al.  Multivariate Relationships Between Peripheral Inflammatory Marker Subtypes and Cognitive and Brain Structural Measures in Psychosis , 2020, Molecular Psychiatry.

[15]  Erick Jorge Canales-Rodríguez,et al.  Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. , 2020, JAMA psychiatry.

[16]  Anders M. Dale,et al.  The genetic architecture of the human cerebral cortex , 2020, Science.

[17]  M. Clerici,et al.  Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis , 2020, Acta Neuropsychiatrica.

[18]  John D. Murray,et al.  Generative modeling of brain maps with spatial autocorrelation , 2020, NeuroImage.

[19]  B. Miller,et al.  Meta‐analysis of total and differential white blood cell counts in schizophrenia , 2019, Acta psychiatrica Scandinavica.

[20]  D. J. Ardesch,et al.  Genetic mapping and evolutionary analysis of human-expanded cognitive networks , 2019, Nature Communications.

[21]  P. Buckley.  Neuroinflammation and Schizophrenia , 2019, Current Psychiatry Reports.

[22]  I. Melle,et al.  Antipsychotic treatment and basal ganglia volumes: Exploring the role of receptor occupancy, dosage and remission status , 2019, Schizophrenia Research.

[23]  A. Griffa,et al.  Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia. , 2019, Schizophrenia bulletin.

[24]  Adrian Preda,et al.  Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium , 2018, Biological Psychiatry.

[25]  Haochang Shou,et al.  On testing for spatial correspondence between maps of human brain structure and function , 2018, NeuroImage.

[26]  Hong Yin,et al.  Disease Definition for Schizophrenia by Functional Connectivity Using Radiomics Strategy , 2018, Schizophrenia bulletin.

[27]  N. Müller.  Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations , 2018, Schizophrenia bulletin.

[28]  Ben D. Fulcher,et al.  A practical guide to linking brain-wide gene expression and neuroimaging data , 2018, NeuroImage.

[29]  P. Meyers,et al.  Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke , 2018, American Journal of Neuroradiology.

[30]  Jun Li,et al.  Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. , 2018, The lancet. Psychiatry.

[31]  M. Fukunaga,et al.  The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects , 2017, NeuroImage: Clinical.

[32]  Costin Tanase,et al.  A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. , 2015, JAMA psychiatry.

[33]  M. Ron,et al.  A longitudinal study of cortical changes and their cognitive correlates in patients followed up after first-episode psychosis , 2014, Psychological Medicine.

[34]  P. Fusar-Poli,et al.  Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis , 2013, Schizophrenia Research.

[35]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[36]  Nancy C. Andreasen,et al.  Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia , 2011, Biological Psychiatry.

[37]  Alan C. Evans,et al.  Changes in cortical thickness during the course of illness in schizophrenia. , 2011, Archives of general psychiatry.

[38]  J. Kwon,et al.  Cortical thickness reduction in individuals at ultra-high-risk for psychosis. , 2011, Schizophrenia bulletin.

[39]  Christian Gieger,et al.  Multiple Loci Are Associated with White Blood Cell Phenotypes , 2011, PLoS genetics.

[40]  Ronald Pierson,et al.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. , 2011, Archives of general psychiatry.

[41]  D. Stein,et al.  What is a mental/psychiatric disorder? From DSM-IV to DSM-V , 2010, Psychological Medicine.

[42]  F. Španiel,et al.  Effect of Low-Frequency rTMS on Electromagnetic Tomography (LORETA) and Regional Brain Metabolism (PET) in Schizophrenia Patients with Auditory Hallucinations , 2007, Neuropsychobiology.

[43]  A. Sampson,et al.  Effect of Chronic Exposure to Antipsychotic Medication on Cell Numbers in the Parietal Cortex of Macaque Monkeys , 2007, Neuropsychopharmacology.

[44]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[45]  Yusuke Nakamura,et al.  Trans-ethnic meta-analysis of white blood cell phenotypes. , 2014, Human molecular genetics.

[46]  John H Krystal,et al.  Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. , 2003, Archives of general psychiatry.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[48]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.